Two Biologics for Psoriatic Arthritis Square Off in Big Trial

Summary
(MedPage Today) -- ORLANDO -- A large head-to-head trial reported here that pitted bimekizumab (Bimzelx) against risankizumab (Skyrizi) as treatment for psoriatic arthritis (PsA) yielded a winner, albeit with a couple caveats. Arthritic symptoms...
Description from Medpagetoday.
Who is covering this
-
Two Biologics for Psoriatic Arthritis Square Off in Big Trial
(MedPage Today) -- ORLANDO -- A large head-to-head trial reported here that pitted bimekizumab (Bimzelx) against risankizumab (Skyrizi) as treatment for psoriatic arthritis (PsA) yielded a winner, albeit with a couple caveats. Arthritic symptoms...
Comments
Comments need JavaScript.